Mitani EBIT per Share
The EBIT per Share of Mitani (8066.T) as of Aug 22, 2026 is 368.32 JPY. In the previous year, EBIT per Share was 289.38 JPY — a change of 27.28% (higher).
Get this data via API
Financial Data API
EBIT per Share
368.32JPY
YoY
27.28%
Last updated:
EBIT per Share of Mitani is 2026 368.32 JPY. EBIT per Share of Mitani was 2025 289.38 JPY. It decreases by 27.28% higher compared to the previous year.
The Mitani EBIT per Share history
3 Years
10 Years
25 Years
Max
EBIT per Share
Date
EBIT per Share
Jan 1, 2018
163.61 JPY
Jan 1, 2019
187.23 JPY
Jan 1, 2020
189.40 JPY
Jan 1, 2021
207.46 JPY
Jan 1, 2022
220.20 JPY
Jan 1, 2023
241.38 JPY
Jan 1, 2024
289.38 JPY
Jan 1, 2025
368.32 JPY
| YEAR | EBIT per Share | YoY |
|---|---|---|
| 368.32JPY | +27.28% | |
| 289.38JPY | +19.89% | |
| 241.38JPY | +9.62% | |
| 220.20JPY | +6.14% | |
| 207.46JPY | +9.54% | |
| 189.40JPY | +1.16% | |
| 187.23JPY | +14.43% | |
| 163.61JPY | +2.80% | |
| 159.15JPY | -16.81% | |
| 191.30JPY | -70.73% | |
| 653.46JPY | +14.65% | |
| 569.96JPY | +26.24% | |
| 451.48JPY | +11.40% | |
| 405.29JPY | +15.52% | |
| 350.82JPY | +23.17% | |
| 284.82JPY | -3.71% | |
| 295.79JPY | -13.12% | |
| 340.46JPY | -4.89% | |
| 357.96JPY | +31.55% | |
| 272.11JPY | — |
Access this data via the Eulerpool API
Mitani Stock analysis
What does Mitani do? Mitani Corp is a Japanese conglomerate that was founded in 1946. The company is based in Osaka and operates in various business sectors. Mitani Corp has undergone a long and successful development throughout its history. The conglomerate started as a small pharmaceutical manufacturer and has evolved into a diverse company over time.
Mitani Corp's core business is now divided into three areas: healthcare, agriculture and food industry, and environmental and energy business. The business divisions have different tasks and pursue different strategies.
In the healthcare sector, Mitani specializes in the development and manufacture of pharmaceutical products, dietary supplements, and medical devices. The sector includes medications and devices for the treatment of cancer, diabetes, cardiovascular diseases, and other chronic illnesses. Mitani Corp is an important player in this field and has gained a good reputation internationally.
Mitani Corp's agriculture and food sector is divided into various segments, including agricultural products, animal feed, feed additives, and pet food. In addition, Mitani owns various food brands that offer a wide range of products such as meat, seafood, bread, sauces, spices, and beverages. In this field, Mitani is interested in selling its products internationally and has business relationships with companies around the world.
Mitani Corp's environmental and energy sector includes various projects and business areas focusing on renewable energy, recycling, and waste disposal. Here, Mitani works on innovative solutions to reduce environmental impact and promote sustainability. The company also invests in renewable energy sources such as wind and solar power.
Mitani Corp is a multidisciplinary company that offers a wide range of products and services. The products offered by the company are innovative and technologically advanced. Mitani Corp places great emphasis on quality and invests in research and development to constantly improve its products and services.
In recent years, Mitani Corp has undergone significant expansion and opened branches worldwide. With sales offices in Japan, North America, Europe, and Asia, it is a key player in the global market. The business fields in which Mitani operates are highly diversified in Japan and other countries and have evolved over time.
Mitani Corp's business model is based on long-term strategic planning and a clear vision. The conglomerate works closely with its customers to understand their needs and provide solutions that meet these requirements. Mitani Corp places great importance on quality and customer satisfaction and has established its reputation in the global market in recent years.
Overall, Mitani Corp is a versatile and innovative conglomerate that operates in various sectors and offers a wide range of products and services. Thanks to its diverse product portfolio, strategic actions, and strong customer orientation, Mitani is successful in various industries and has become a key player in the global market. Mitani is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Mitani stock
EBIT per Share of Mitani is 368.32 JPY in 2026.
EBIT per Share of Mitani changed from 289.38 JPY to 368.32 JPY, representing a 27.28% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Mitani since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Mitani
All Key Metrics — Mitani
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth